CD8A and neoplasm: Another study also found phenotypic changes of CD8+ tumour-infiltrating lymphocytes (TILs) in distal biopsy site of patients with liver metastasis, supporting the possibility that invasion of cancer cells into the liver may trigger liver-specific tolerance mechanisms, thereby reducing the efficacy of systemic antitumor immunotherapy [38].